Pain reduction in PD patients with depression: double blind, randomized clinical trial of duloxetine Pain reduction in PD patients with depression: double blind, randomized clinical trial of duloxetine ...
A double-blind, randomized clinical trial to evaluate the efficacy of Duloxetine against pain associated with Parkinson's disease with depression - Pain reduction in PD patients with depression: double blind, randomized clinical trial of duloxetine A double-blind, randomized clinical trial to evaluate the efficacy of Duloxetine against pain associ ...
Parkinson's disease;D010300
The treatment groups consist of an active treatment arm (40mg/day Duloxetine) and a placebo arm. During the Titration Period (2 weeks), all subjects will be started on 1 capsule (10mg or placebo). During the Maintenance Period (10 weeks), subjects will take 2 capsules. Subjects who are unable to increase their dose can stay at 1 capsule. The treatment groups consist of an active treatment arm (40mg/day Duloxetine) and a placebo arm. Dur ...
A double-blind, randomized, placebo-controlled study of the safety and efficacy of SYN115 as adjunctive therapy in levodopa-treated Parkinson’s subjects with end of dose wearing off - (none) A double-blind, randomized, placebo-controlled study of the safety and efficacy of SYN115 as adjunct ...